Evaluating the impact on quality of life of chemoradiation in gastric cancer

Current Oncology

Volumn 17, Issue 4, 2010, Pages 77-84

  Kassam, Z ^a,b   Mackay, H ^b,c   Buckley, C A ^a   Fung, S ^c   Pintile, M ^c   Kim, J ^a,b   Ringash, J ^a,b  

^a Department of Radiation Medicine ^*  (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Chemoradiation; Gastric cancer; Quality of life

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ANOREXIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURVIVOR; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEHYDRATION; DIARRHEA; DISEASE SEVERITY; DRUG DOSE ESCALATION; DRY SKIN; DYSPNEA; ERYTHEMA; FATIGUE; FEMALE; FOLLOW UP; GASTRITIS; GASTROINTESTINAL TOXICITY; HAND FOOT SYNDROME; HUMAN; HYPONATREMIA; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; NAUSEA AND VOMITING; NEUTROPENIA; OVERALL SURVIVAL; PAIN; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RASH; SEPSIS; SIDE EFFECT; SKIN TOXICITY; SLEEP DISORDER; STOMACH ADENOCARCINOMA; VOMITING; WEIGHT REDUCTION;

EID: 78149428003     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.v17i4.522     Document Type: Article

References (32)

1. Kaasa S, Bjordal K, Aaronson N, et al. The eortc core Quality of Life Questionnaire (qlq-C30): validity and reliability when analysed with patients treated with palliative radiotherapy. Eur J Cancer 1995;31A:2260-3.
2. Blazeby JM, Conroy T, Bottomley A, et al. Clinical and psychometric validation of a questionnaire module, the eortc qlq-STO22, to assess quality of life in patients with gastric cancer. Eur J Cancer 2004;40:2260-8.
3. Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001;345:725-30.
4. Ajani JA, Fodor MB, Tjulandin SA, et al. Phase ii multi-institutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated, advanced gastric, or gastroesophageal adenocarcinoma. J Clin Oncol 2005;23:5660-7.
5. Kassam Z, MacKay H, Buckley CA, et al. Adjuvant chemoradiation for gastric cancer with infusional 5-fluorouracil and cisplatin: a phase i study. Curr Oncol 2010;17:95-104.
6. Kassam Z, Lockwood G, O'Brien C, et al. Conformal radiotherapy in the adjuvant treatment of gastric cancer: review of 82 cases. Int J Radiat Oncol Biol Phys 2006;65:713-19.
7. Ringash J, Khaksar SJ, Oza A, et al. Post-operative radiochemotherapy for gastric cancer: adoption and adaptation. Clin Oncol (R Coll Radiol) 2005;17:91-5.
8. Koller M, Lorenz W. Quality of life research in patients with rectal cancer: traditional approaches versus a problem-solving oriented perspective. Langenbecks Arch Surg 1998;383:427-36.
9. United States, National Institutes of Health, National Cancer Institute, Cancer Therapy Evaluation Program (ctep). Common Toxicity Criteria (CTC). Version 2. Bethesda, MD: ctep; 1999. [Available online at: ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcv20_4-30-992.pdf; cited June 8, 2010]
10. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer qlq-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-76.
11. Osoba D, Aaronson N, Zee B, Sprangers M, te Velde A. Modification of the eortc qlq-C30 (version 2.0) based on content validity and reliability testing in large samples of patients with cancer. The Study Group on Quality of Life of the eortc and the Symptom Control and Quality of Life committees of the nci of Canada Clinical Trials Group. Qual Life Res 1997;6:103-8.
12. Osoba D, Zee B, Pater J, Warr D, Kaizer L, Latreille J. Psychometric properties and responsiveness of the eortc Quality of Life Questionnaire (qlq-C30) in patients with breast, ovarian and lung cancer. Qual Life Res 1994;3:353-64.
13. Bjordal K, Kaasa S. Psychometric validation of the eortc core Quality of Life Questionnaire, 30-item version and a diagnosis-specific module for head and neck cancer patients. Acta Oncol 1992;31:311-21.
14. Ringdal GI, Ringdal K. Testing the eortc Quality of Life Questionnaire on cancer patients with heterogeneous diagnoses. Qual Life Res 1993;2:129-40.
15. Niezgoda HE, Pater JL. A validation study of the domains of the core eortc quality of life questionnaire. Qual Life Res 1993;2:319-25.
16. Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998;16:139-44.
17. Neymark N, Kiebert W, Torfs K, et al. Methodological and statistical issues of quality of life (qol) and economic evaluation in cancer clinical trials: report of a workshop. Eur J Cancer 1998;34:1317-33.
18. Barbour AP, Lagergren P, Hughes R, Alderson D, Barham CP, Blazeby JM. Health-related quality of life among patients with adenocarcinoma of the gastro-oesophageal junction treated by gastrectomy or oesophagectomy. Br J Surg 2008;95:80-4.
19. Tyrvainen T, Sand J, Sintonen H, Nordback I. Quality of life in the long-term survivors after total gastrectomy for gastric carcinoma. J Surg Oncol 2008;97:121-4.
20. Wu CW, Chiou JM, Ko FS, et al. Quality of life after curative gastrectomy for gastric cancer in a randomised controlled trial. Br J Cancer 2008;98:54-9.
21. Thybusch-Bernhardt A, Schmidt C, Kuchler T, Schmid A, Henne-Bruns D, Kremer B. Quality of life following radical surgical treatment of gastric carcinoma. World J Surg 1999;23:503-8.
22. Lee MK, Lee KM, Bae JM, et al. Employment status and work-related difficulties in stomach cancer survivors compared with the general population. Br J Cancer 2008;98:708-15.
23. Langendijk JA, Aaronson NK, de Jong JM, et al. Quality of life after curative radiotherapy in stage i non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2002;53:847-53.
24. Langendijk JA, Aaronson NK, de Jong JM, et al. Prospective study on quality of life before and after radical radiotherapy in non-small-cell lung cancer. J Clin Oncol 2001;19:2123-33.
25. Curran D, van Dongen JP, Aaronson NK, et al. Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: results of eortc trial 10801. The European Organization for Research and Treatment of Cancer (eortc), Breast Cancer Co-operative Group (bccg). Eur J Cancer 1998;34:307-14.
26. Bjordal K, Kaasa S, Mastekaasa A. Quality of life in patients treated for head and neck cancer: a follow-up study 7 to 11 years after radiotherapy. Int J Radiat Oncol Biol Phys 1994;28:847-56.
27. Langendijk JA, ten Velde GP, Aaronson NK, de Jong JM, Muller MJ, Wouters EF. Quality of life after palliative radiotherapy in non-small cell lung cancer: a prospective study. Int J Radiat Oncol Biol Phys 2000;47:149-55.
28. Osoba D, Tannock IF, Ernst DS, Neville AJ. Health-related quality of life in men with metastatic prostate cancer treated with prednisone alone or mitoxantrone and prednisone. J Clin Oncol 1999;17:1654-63.
29. Ringash J, Warde P, Lockwood G, O'Sullivan B, Waldron J, Cummings B. Postradiotherapy quality of life for head-and-neck cancer patients is independent of xerostomia. Int J Radiat Oncol Biol Phys 2005;61:1403-7.
30. Litwin MS, Flanders SC, Pasta DJ, Stoddard ML, Lubeck DP, Henning JM. Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from capsure. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology 1999;54:503-8.
31. Madalinska JB, Essink-Bot ML, de Koning HJ, Kirkels WJ, van der Maas PJ, Schroder FH. Health-related quality of life in patients with screen-detected versus clinically diagnosed prostate cancer preceding primary treatment. Prostate 2001;46:87-97.
32. Fowler FJ Jr, Barry MJ, Lu-Yao G, Wasson J, Roman A, Wennberg J. Effect of radical prostatectomy for prostate cancer on patient quality of life: results from a Medicare survey. Urology 1995;45:1007-13.